efavirenz and Dermatitis Medicamentosa

efavirenz has been researched along with Dermatitis Medicamentosa in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (66.67)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, S; Kohli, S; Mahajan, VK; Rashpa, RS1
Bayonne Kombo, ES; Gathse, A1
Achan, J; Ades, V; Aliba Luwedde, F; Clark, T; Cohan, D; Havlir, D; Kakuru, A; Kamya, M; Mwesigwa, J; Natureeba, P; Osterbauer, B; Plenty, A1
Bertelli, A; D'Erme, AM; Gola, M; Severino, M; Tchoimou, T; Testi, S; Tiradritti, L; Zuccati, G1
Fulgaro, C; Rosticelli, E; Sabbatani, S1
Alsina, MM; Blanco, JL; Lecha, M; López-Lerma, I1
Furue, M1
Konishi, M; Maeda, K; Mikasa, K; Murakawa, K; Takahashi, K; Yamashina, Y; Yoshimoto, E1
Maartens, G; Mehta, U1
Borot, N; Hovnanian, A; Ledger, TN; Lefebvre, A; Lonjou, C; Milpied, B; Vitezica, ZG1
Barreiro, P; Dona, C; González-Lahoz, J; Soriano, V1
Kikuchi, Y; Oka, S; Yazaki, H1

Reviews

2 review(s) available for efavirenz and Dermatitis Medicamentosa

ArticleYear
Photodermatitis in a woman on antiretroviral therapy: report of a rare cutaneous adverse drug reaction of efavirenz and review of literature.
    International journal of dermatology, 2017, Volume: 56, Issue:10

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Eruptions; Female; Humans; Photosensitivity Disorders

2017
Is it safe to switch between efavirenz and nevirapine in the event of toxicity?
    The Lancet. Infectious diseases, 2007, Volume: 7, Issue:11

    Topics: Alkynes; Benzoxazines; Chemical and Drug Induced Liver Injury; Cross Reactions; Cyclopropanes; Drug Eruptions; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors

2007

Trials

1 trial(s) available for efavirenz and Dermatitis Medicamentosa

ArticleYear
WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity.
    Journal of acquired immune deficiency syndromes (1999), 2013, Mar-01, Volume: 62, Issue:3

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Breast Feeding; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Drug Eruptions; Drug Substitution; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lopinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Ritonavir; Uganda; World Health Organization

2013

Other Studies

9 other study(ies) available for efavirenz and Dermatitis Medicamentosa

ArticleYear
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Medecine et maladies infectieuses, 2013, Volume: 43, Issue:3

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asthenia; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity; Drug Substitution; Emtricitabine; Female; Fever; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Syndrome; Tenofovir

2013
Two cases of successful efavirenz desensitization in patients with several anti-HIV drugs hypersensitivities.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015, Volume: 150, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Female; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors

2015
[Efficacy of efavirenz in a mixed population of patients. Identification of drop-out causes].
    Le infezioni in medicina, 2002, Volume: 10, Issue:3

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Eruptions; Drug Evaluation; Female; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Oxazines; Patient Dropouts; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

2002
Photodermatitis in a patient with HIV infection.
    Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Eruptions; Female; HIV Infections; Humans; Oxazines; Photosensitivity Disorders

2003
Photosensitive drug eruption induced by efavirenz in a patient with HIV infection.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:7

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dermatitis, Photoallergic; Drug Eruptions; Follow-Up Studies; HIV Infections; Humans; Japan; Male; Middle Aged; Oxazines; Risk Assessment

2004
The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:7

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dermatitis, Photoallergic; Drug Eruptions; Follow-Up Studies; HIV Infections; Humans; Japan; Male; Middle Aged; Oxazines; Photosensitivity Disorders; Risk Assessment; Severity of Illness Index

2004
HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz.
    AIDS (London, England), 2008, Feb-19, Volume: 22, Issue:4

    Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Eruptions; Female; HIV Infections; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Male; Middle Aged; Nevirapine; Prospective Studies

2008
Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
    AIDS (London, England), 2000, Jul-28, Volume: 14, Issue:11

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Eruptions; Exanthema; HIV Infections; Humans; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors

2000
Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.
    Japanese journal of infectious diseases, 2001, Volume: 54, Issue:6

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Eruptions; Female; HIV Infections; HIV-1; Humans; Lamivudine; Oxazines; Spouses; Stavudine; Time Factors

2001